BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• Biotech Bay

  Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting

  Annexon, Inc. today announced the Company will have two presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held May 5-9, 2024 in Seattle, Washington.

  May 1, 2024

   · 

  7 min read
• Genetown

  Boston Scientific Announces Upcoming Investor Conference Schedule

  Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.

  May 1, 2024

   · 

  1 min read
• Deals

  INOVIO Reports Inducement Grants Under Inducement Plan - May 1, 2024

  INOVIO today announced that it has made equity grants to two newly hired employees under its 2022 Inducement Plan (the “Inducement Plan”).

  May 1, 2024

   · 

  1 min read
• Biotech Bay

  Benitec Biopharma to Participate in the Citizens JMP Life Science Conference

  Benitec Biopharma Inc. today announced that members of Benitec management will participate in Citizens JMP Life Science Conference, taking place in New York, NY from May 13-14, 2024.

  May 1, 2024

   · 

  1 min read
• Genetown

  Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference

  Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer of Prime Medicine, will participate in a panel discussion at the 27th Annual Milken Institute Global Conference entitled “Things That Will Blow Your Mind.”

  May 1, 2024

   · 

  2 min read
• Biotech Bay

  4DMT Announces Presentations at ARVO 2024 Annual Meeting

  4D Molecular Therapeutics today announced presentations at the 2024 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Seattle, Washington on May 5-9, 2024.

  May 1, 2024

   · 

  2 min read
• Business

  ImmuneSensor Therapeutics Appoints Veteran Biopharma Executive, Thomas W. Dubensky, Jr., Ph.D., as Chief Executive Officer

  ImmuneSensor Therapeutics announced the appointment of Thomas W. Dubensky, Jr., Ph.D., as president and chief executive officer and a member of the Board of Directors, effective immediately.

  May 1, 2024

   · 

  5 min read
• FDA

  US FDA approves high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm) injection, Boehringer Ingelheim’s interchangeable* biosimilar to Humira®

  Boehringer Ingelheim announced today that the U.S. Food and Drug Administration (FDA) has approved the high-concentration, citrate-free formulation of Cyltezo® (adalimumab-adbm), the company’s interchangeable* biosimilar to Humira® (adalimumab), to treat multiple chronic inflammatory diseases.

  May 1, 2024

   · 

  11 min read
• Genetown

  Avilar Therapeutics to Present Preclinical Data for MTAC (M6PR Targeting Chimera) Extracellular Protein Degrader Platform at the American Association of Immunologists Annual Meeting

  Avilar Therapeutics today announced it will present preclinical proof-of-concept data for the company’s MTAC (M6PR Targeting Chimera) protein degrader platform at IMMUNOLOGY™ 2024, the American Association of Immunologists annual meeting.

  May 1, 2024

   · 

  3 min read
• Biotech Bay

  OmniAb to Participate in Five Investor Conferences in May

  OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five investor conferences during the month of May.

  May 1, 2024

   · 

  3 min read